Quo­tient, buoyed by Covid-19 work, buys Ar­ci­no­va in ef­fort to build end-to-end CD­MO brand

Flush with cash from Covid-19 work, con­tract man­u­fac­tur­ers are hav­ing their own M&A mi­ni-boom. Now, a UK-based man­u­fac­tur­ing ser­vices firm is snag­ging an­oth­er com­pa­ny head­quar­ter on the Isles, look­ing to set up an end-to-end of­fer­ing for cus­tomers.

Not­ting­ham drug de­vel­op­er and man­u­fac­tur­ing ac­cel­er­a­tor Quo­tient an­nounced plans this week to buy Ar­ci­no­va, an­oth­er con­tract de­vel­op­er with over four decades in the in­dus­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER